HanchorBio Inc. (TPEX:7827)
Taiwan · Delayed Price · Currency is TWD 137.00
-8.00 (-5.52%)
At close: May 29, 2026
HanchorBio Market Cap
HanchorBio has a market cap or net worth of 17.81 billion as of May 29, 2026.
Market Cap
17.81B
Enterprise Value
17.00B
Revenue
312.22M
Ranking
n/a
PE Ratio
n/a
Stock Price
137.00
Market Cap Chart
Since June 20, 2025, HanchorBio's market cap has increased from 5.52B to 17.81B, an increase of 222.66%. That is a compound annual growth rate of 247.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 17.81B | 54.63% |
| Dec 31, 2025 | 11.52B | 108.67% |
| Jun 20, 2025 | 5.52B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elixiron Immunotherapeutics (Cayman) Limited | 9.44B |
| Uwell Biopharma | 7.99B |
| Intelligene | 6.76B |
| Obigen Pharma | 3.97B |
| Pet Pharm Biotech | 3.09B |
| BIONET Therapeutics | 2.66B |
| FullHope Biomedical | 1.23B |
| Genomics BioSci & Tech. | 1.20B |